Summary
We recently reported a potentiating effect of recombinant human interleukin-1β on glucose-stimulated insulin release from the isolated perfused pancreas. With the aim of determining whether the stimulatory effect of recombinant interleukin-1β on the B cell in the intact gland was modulated by varying the concentration, time of exposure to recombinant interleukin-1β or B-cell activity, and to elucidate a possible mechanism of action, we measured in the perfused rat pancreas the release of insulin, glucagon and/or prostaglandin E2 according to the following three different protocols: (1) perfusion with 20 ng/ml of recombinant interleukin-1β for 92 min at 5 and 20 mmol/1 D-glucose (2) perfusion with varying concentrations of recombinant interleukin-1β ranging from 0.1×10−3 ng/ml to 100 ng/ml at 5 and 20 mmol/l D-glucose (3) perfusion with 20 ng/ml of recombinant interleukin-1β at 5,11 or 20 mmol/l D-glucose. Furthermore, in a separate set of experiments we examined the influence of the cytokine on the morphology of the endocrine pancreas. Interleukin-1β stimulated insulin secretion at 11 and 20 mmol/l D-glucose and potentiated first as well as second phase insulin release in a dose-dependent fashion, with decreasing effect at higher concentrations. Glucagon secretion was also stimulated by recombinant interleukin-1β, irrespective of increasing glucose (5, 11, 20 mmol/l) and insulin concentrations. The potentiating effect of recombinant interleukin-1β on insulin secretion was evident even after discontinued perfusion with the cytokine, suggesting a priming effect on B-cell function. Furthermore, we did not observe any relation between the recombinant interleukin-1β mediated insulin and glucagon release and prostaglandin E2. Electron microscopy of the pancreata perfused with recombinant interleukin-1β revealed significant B cell and to a lesser extent A-cell lysis as well as induction of cell protrusions (“blebs”) in B cells only, accompanied by peripheral degranulation and rearrangement of rough endoplasmatic reticulum. We suggest that in addition to a paracrine effect of locally produced interleukin-1β systemic interleukin-1β may have an endocrine effect on A- and B-cell function and viability. Interleukin-1β should be considered to be a physiological modulator of insulin and glucagon secretion e.g. during the acute phase response, but also as a pathogenetic factor in Type 1 (insulin-dependent) diabetes mellitus.
Article PDF
Similar content being viewed by others
References
Dinarello CA (1988) Biology of interleukin-1. FASEB J 2: 108–115
Schultzberg M, Svenson SB, Unden A, Bartfai T (1987) Interleukin-1-like immunoreactivity in peripheral tissues. J Neurosci Res 18: 184–189
Mandrup-Poulsen T (1988) On the pathogenesis of insulin dependent diabetes mellitus. Dan Med Bull 35: 438–460
Spinas GA, Palmer JP, Mandrup-Poulsen T, Andersen H, Nielsen JH, Nerup J (1988) The bimodal effect of interleukin-1 on rat pancreatic beta-cells — stimulation followed by inhibition — depends upon dose, duration of exposure and ambient glucose concentration. Acta Endocrinol (Copenh) 118: 307–311
Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L, Egeberg J (1988) Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care 11 [Suppl. 1]: 16–23
Samols E, Stagner JI, Ewart RBL, Marks V (1988) The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas. J Clin Invest 82: 350–353
Wogensen LD, Mandrup-Poulsen T, Markholst H, Lernmark Å, Holst JJ, Dinarello CA, Nerup J (1988) Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. Acta Endocrinol (Copenh) 117: 302–306
Svenningsen A, Dyrberg T, Markholst H, Binder C, Lernmark Å (1986) Insulin release and pancreatic insulin is reduced in young prediabetic BB rats. Acta Endocrinol 112: 367–371
Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RN, Webb AC, Auron PE, Reuben RC, Rich A, Wolff SM, Putney SD (1986) Multiple biological activities of human recombinant interleukin-1. J Clin Invest 77: 1734–1739
Dalbøge H, Bayne S, Christensen T, Heinæs KR (1989) Cloning and expression of an interleukin-1β precursor and its conversion to interleukin-1β. FEBS 246: 89–93
Christensen P, Leyssac PP (1976) A specific radioimmunoassay for PGE2 using antibody with high specificity and a Sephadex LH-20 microcolumn for the separation of prostaglandins. Prostaglandins 11: 399–420
Christensen P, Green K, Leyssac PP (1983) The relationship between urinary prostaglandin excretion rates and urine flow in conscious rats. Evaluation of the radioimmunoassay by gas chromatography-mass spectrometry. Acta Physiol Scand 117: 41–47
Spurr A (1969) A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26: 31–43
Farber S (1982) Biology of disease: membrane injury and calcium homeostasis in the pathogenesis of coagulation necrosis. Lab Invest 47: 114–123
Cornell RP (1983) Role of the liver in endotoxin-induced hyperinsulinemia and hyperglucagonemia in rats. Hepatology 3: 188–192
Yelich MR, Filkins JP (1980) Mechanism of hyperinsulinemia in endotoxicosis. Am J Physiol 239: E156-E161
Yelich MR, Filkins JP (1984) Role of calcium in the insulin hypersecretory state of the endotoxic rat pancreas. Circ Shock 14: 49–62
Filkins JP, Yelich MR (1982) Mechanism of hyperinsulinemia after reticuloendothelial system phagocytosis. Am J Physiol 242: E115-E120
del Rey A, Besedovsky H (1987) Interleukin-1 affects glucose homeostasis. Am J Physiol 253: R794-R798
Pomposelli JJ, Flores EA, Bistrian BR (1988) Role of biochemical mediators in clinical nutrition and surgical metabolism. J Parent Ent Nutrition 12: 212–218
Yelich MR, Umporowicz DM, McCulla EA, Filkins JP (1987) Interleukin-1 (IL-1) in vivo potentiates immunoreactive insulin (IRI) secretion in the in vitro perfused rat pancreas. FED PROC 46: 4 (Abstract)
Reuter A, Bernier J, Gysen P, Gevaert Y, Gathy R, Lopez M, Dupont G, Damas P, Franchimont (1988) A RIA for tumor necrosis factor (TNFα) and interleukin 1β (IL-1β) and their direct determination in serum. In: Powanda MC (ed) Monokines and other non-lymphocytic cytokines. Alan R. Liss, New York, pp 377–381
Girardin E, Grau GE, Dayer JM, Roux-Lombard P, The J5 Study Group, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319: 397–400
Spinas GA, Palmer JP, Egeberg J, Mandrup-Poulsen T, Andersen HU, Nielsen JH, Nerup J (1988) Differential effects of interleukin-1 on pancreatic alpha and beta cells. Diabetes 37 [Suppl.1]: 202 (Abstract)
Scanlon M, Laster SM, Wood JG, Gooding LR (1989) Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments. Proc Natl Acad Sci USA 86: 182–186
Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA (1987) Ultrastructural studies of time course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Path Microbiol Immunol Scand (C) 95: 55–63
Sandler S, Bendtzen K, Borg LAH, Eizirik DL, Strandell E, Welsh N (1989) Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1β indicate a perturbation in the mitochondrial function. Endocrinology 124: 1492–1501
Palmer J, Helqvist S, Spinas GA, Mølvig J, Mandrup-Poulsen T, Andersen HU and Nerup J (1989) Interaction of beta-cell activity and interleukin-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38: 1211–1216
Schuit FC, In'T Veld PA, Pipeleers DG (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci US A 85: 3865–3869
Goodman M, Wang Y, Lumerman J, Sussman KE, Lafferty K, Drazin B (1988) Studies on the mechanism causing the impairment of glucose-stimulated insulin release in rat pancreatic islets exposed to human recombinant interleukin-β. Diabetes 37 [Suppl.1]: 21 (Abstract)
Gerich JE (1983) Glucose in the control of glucagon secretion. In: Lefebvre PJ (ed) Handbook of experimental pharmacology, Vol 66: Glucagon II. Springer, Berlin Heidelberg New York, pp 3–18
Zawalich WS, Dierolf B, Zawalich K (1989) Interleukin-1 induces time-dependent potentiation in isolated rat islets: possible involvement of phosphoinositide hydrolysis. Endocrinology 124: 720–726
Roh MS, Drazenovich KA, Barbose JJ, Dinarello CA (1987) Direct stimulation of the adrenal cortex by interleukin-1. Surgery 102: 140–146
Turk J, Colca JR, Kotagal N, McDaniel ML (1984) Identification and quantitation of lipoxygenase and cyclooxygenase products. I. Biochim Biophys Acta 794: 110–114
Turk J, Colca JR, Kotagal N, McDaniel ML (1984) Identification and quantitation of lipoxygenase and cyclooxygenase products. II. Biochim Biophys Acta 794: 125–136
Luyckx AS, Lefebre PJ (1983) Prostaglandins and glucagon secretion. In: Lefebvre PJ (ed) Handbook of exerimental pharmacology, Vol 66: Glucagon II. Springer, Berlin Heidelberg New York, pp 83–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wogensen, L.D., Kolb-Bachofen, V., Christensen, P. et al. Functional and morphological effects of interleukin-1β on the perfused rat pancreas. Diabetologia 33, 15–23 (1990). https://doi.org/10.1007/BF00586456
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00586456